共 91 条
[8]
Althoff E., 2016, Novartis BAF312 reduces the risk of disability progression in pivotal phase III study in secondary progressive MS patients | Novartis
[10]
Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2016, 27 (04)
:1076-1090